Safety, Tolerability and PK of Single and Multiple Doses of Oxantel Pamoate Tablets

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 27, 2025

Primary Completion Date

April 8, 2025

Study Completion Date

April 8, 2025

Conditions

Healthy

Interventions

DRUG

Oxantel Pamoate

Oxantel Pamoate tablet, 250mg

DRUG

Placebo

Placebo tablet

Trial Locations (1)

Ifakara Health Institute, Bagamoyo

All Listed Sponsors

collaborator

Ifakara Health Institute

OTHER

collaborator

Drugs for Neglected Diseases initiative

UNKNOWN

lead

Swiss Tropical & Public Health Institute

OTHER

NCT06606860 - Safety, Tolerability and PK of Single and Multiple Doses of Oxantel Pamoate Tablets | Biotech Hunter | Biotech Hunter